C07K 16/082
Hepadnaviridae
Official title: Hepadnaviridae (F), e.g. hepatitis B virus
C07K16/082 (Hepadnaviridae) appears on 171 US grants and 280 published applications in this corpus.
Search patents in C07K- Granted patents
- 171
- Published applications
- 280
- Assignees
- 151
- Inventors
- 565
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 6 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 7 |
| 2003 | 5 | 10 |
| 2004 | 1 | 7 |
| 2005 | 3 | 7 |
| 2006 | 7 | 8 |
| 2007 | 3 | 9 |
| 2008 | 7 | 7 |
| 2009 | 1 | 6 |
| 2010 | 4 | 17 |
| 2011 | 2 | 5 |
| 2012 | 8 | 8 |
| 2013 | 5 | 4 |
| 2014 | 7 | 9 |
| 2015 | 3 | 15 |
| 2016 | 8 | 9 |
| 2017 | 8 | 11 |
| 2018 | 3 | 22 |
| 2019 | 14 | 19 |
| 2020 | 8 | 8 |
| 2021 | 3 | 16 |
| 2022 | 6 | 18 |
| 2023 | 9 | 19 |
| 2024 | 4 | 13 |
| 2025 | 10 | 15 |
| 2026 | 5 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods related to human neutralizing antibodies to hepatitis B29 Sep 2026US 12,747,283 B2The Rockefeller University
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof30 Jun 2026US 12,668,645 B2ModeX Therapeutics, Inc.
- Binding molecules specific for HBV envelope protein19 May 2026US 12,630,610 B2Immunocore Limited
- Method and antibody for detection of HBcAg12 May 2026US 12,624,090 B2Xiamen Innodx Biotech Co., Ltd
- Systems to produce B cells genetically modified to express selected antibodies31 Mar 2026US 12,589,145 B2Fred Hutchinson Cancer Center
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Recombinant polyclonal proteins targeting hepatitis b virus (hbv) and methods of use thereof10 Sep 2026US 2026/0265345 A1GigaGen, Inc.
- Methods of analyzing recombinant polyclonal proteins3 Sep 2026US 2026/0259221 A1GigaGen, Inc.
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Antibody against hepatitis b virus, preparation thereof and use thereof27 Aug 2026US 2026/0250361 A1Huahui Health Ltd.
Most cited
By later US patents
- Immunoassay utilizing monoclonal high affinity IgM antibodies286US 4,879,219 AThe General Hospital Corporation · 1989
- Fc variants with altered binding to FcRn193US 8,367,805 B2Xencor, Inc. · 2013
- Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis156US 7,217,797 B2PDL BioPharma, Inc. · 2007
- Fc variants with altered binding to FcRn94US 8,088,376 B2Xencor, Inc. · 2012
- Retro-, inverso- and retro-inverso synthetic peptide analogues90US 6,261,569 B1Deakin Research Limited · 2001